WEHL-03

CAS No. 15827-80-2

WEHL-03( 4-AMINO-3-CYANO-1,2,5,6-TETRAHYDROPYRIDINE )

Catalog No. M27586 CAS No. 15827-80-2

WEHL-03 is an active chemical.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 352 Get Quote
10MG 524 Get Quote
25MG 839 Get Quote
50MG 1143 Get Quote
100MG 1521 Get Quote
500MG 3078 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    WEHL-03
  • Note
    Research use only, not for human use.
  • Brief Description
    WEHL-03 is an active chemical.
  • Description
    WEHL-03 is an active chemical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    4-AMINO-3-CYANO-1,2,5,6-TETRAHYDROPYRIDINE
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Calpain
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    15827-80-2
  • Formula Weight
    123.16
  • Molecular Formula
    C6H9N3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    NC(CCNC1)=C1C#N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Brad Owen BUCKMAN, et al. Calpain modulators and therapeutic uses thereof. WO2018064119A1.
molnova catalog
related products
  • EC330

    EC330 a novel steroidal LIF inhibitor showed cytotoxicity in various cancer cell lines and NCI-60 cell line panel at low nano-molar range.

  • Tranilast

    A compound that exhibits anti-inflammatory and immunomodulatory effects by inhibiting lipid mediator and cytokine release from inflammatory cells and interfering with PDGF- and TGF-β1-induced proliferation and migration of vascular medial smooth muscle cells.

  • L-allo-Isoleucine

    L-alloisoleucine is a branched chain amino acid and is a stereoisomer of L-isoleucine. It is a common constituent of human plasma (albeit at low levels). L-alloisoleucine is produced as a byproduct of isoleucine transamination. Plasma L-alloisoleucine which is derived from L-isoleucine in vivo can be used for the diagnosis of maple syrup urine disease (MSUD) a genetic disorder.